VEEPRHO is a GMP and ISO certified manufacturer and supplier of Impurity Reference Standards

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Veeprho Pharmaceuticals s.r.o
Radiova 1122/1, 102 27, Praha 10-Hostivař,
Czech Republic, European Union

Contact number

+420-773 033 992

+420 773 033 980

Email address: [email protected]

Website – www.veeprho.com

VEEPRHO is a global manufacturer and supplier of Impurity Reference Standards for the Pharmaceutical industry. Our global network is comprised of our headquarters in Czech Republic EU, manufacturing and R&D facilities in India, as well as distribution offices in New Jersey US, and United Kingdom equipped to provide immediate support within all time zones.

VEEPRHO is an emerging, research-based global pharmaceutical company with a diverse combination of skills, resources, and capabilities that provide the platform to perform effectively in today’s rapidly changing healthcare environment.

Our vision is to provide high-quality products around the world to support the Pharmaceutical Industry in making compounds free of errors and establishing a community with risk-free medical treatment. Reference Standards are the supporting blocks of the medical industry, and our initiative is to contribute the best we can to enable the functioning of proper and reliable treatment.

Nitrosamine Analysis in the Pharma Industry: Trends, Challenges, and Future Perspectives

11/14/2024 | Sponsored by LGC